Change in plasma cryptococcal antigen titer is not associated with survival among human immunodeficiency virus-infected persons receiving preemptive therapy for asymptomatic cryptococcal antigenemia

Matthew F. Pullen, Francis Kakooza, Elizabeth Nalintya, Agnes N. Kiragga, Bozena M. Morawski, Radha Rajasingham, Anthony Mubiru, Yukari C. Manabe, Jonathan E. Kaplan, David B. Meya, David R. Boulware

Research output: Contribution to journalLetter

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)353-355
Number of pages3
JournalClinical Infectious Diseases
Issue number2
StatePublished - Jan 15 2020

Cite this